Global craniomaxillofacial implants market, by Product Type (Bone Graft Substitutes, Distraction Systems, Total TMJ Replacement Systems, Cranial Flap Fixation Systems, Thoracic Fixation Systems, Dural Repair Products, Screws, Plates and Contourable Mesh), by Raw Material (Metals, Ceramics, Polymers, and Biomaterials), by Application (Internal Fixators and External Fixators), by Property (Resorbable Fixators and Non-Resorbable Fixators), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 2,289.5 million in 2019 and is projected to exhibit a CAGR of 6.2% over the forecast period (2019–2027).
Increasing demand for reconstruction surgeries has led to increase the focus of key players to develop advanced maxillofacial implants, this is projected to drive the global craniomaxillofacial implants market growth over the forecast period.
Manufacturers are focusing on developing innovative products and gaining regulatory approval for their products, this is expected to boost the global craniomaxillofacial implants market growth. For instance, in January 2017, OssDsign AB, a Swedish designer, manufacturer, and distributor of next generation craniomaxillofacial implants, received FDA clearance for marketing and sales of OSSDSIGN Cranial PSI in the U.S. Manufacturers are further focusing on developing craniomaxillofacial implants that are more biocompatible and resistant to corrosion.
Moreover, in May 2019, Kelyniam Global (KLYG), a manufacturer of custom cranial and craniofacial implants, received premarket approval from the U.S. Food and Drug Administration (FDA) for a new cranio-maxillofacial skull implants. Matrix Surgical USA also received a 510(k) clearance to market its ‘OmniPore Duromax’ Surgical craniofacial implant in October 2018.
Furthermore, in February 2018, Mininavident AG received the CE (Conformité Européenne) Mark approval for its DENACAM system. This 3D navigation system is an integrated system used in dental practices and cranio-maxillofacial surgery.
Increasing awareness about craniomaxillofacial surgeries among people and health care professionals is also expected to drive the global craniomaxillofacial implants market growth. For instance, in October 2018, The Vice President of India said that the role of oral and maxillofacial surgeons in the society is of paramount importance and indispensable, especially during the time of tragic accidents or oral cancers. He also discussed and shared information about the importance and benefits of oral and maxillofacial surgeries with an aim of creating awareness for the same at 43rd National Conference of Oral & Maxillofacial Surgeons of India.
Browse 44 Market Data Tables, and 34 Figures spread through 185 Pages and in-depth TOC on Global Craniomaxillofacial Implants Market, by Product Type (Bone Graft Substitutes, Distraction Systems, Total TMJ Replacement Systems, Cranial Flap Fixation Systems, Thoracic Fixation Systems, Dural Repair Products, Screws, Plates and Contourable Mesh), by Raw Material (Metals, Ceramics, Polymers, and Biomaterials), by Application (Internal Fixators and External Fixators), by Property (Resorbable Fixators and Non-Resorbable Fixators), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Global Forecast to 2027
To know the latest trends and insights prevalent in the global craniomaxillofacial implants market, click the link below:
https://www.coherentmarketinsights.com/market-insight/craniomaxillofacial-implants-market-773
Market players are adopting inorganic growth strategies such as collaboration to strengthen their product portfolio of craniomaxillofacial implants. For instance, Materialize NV, headquartered in Belgium, announced a collaboration with DePuy Synthes, a subsidiary of Johnson & Johnson, in July 2016. As a part of the collaboration, Materialise NV will manufacture patient specific craniomaxillofacial implants utilizing its 3D printing expertise, which would be offered through DePuy Synthes TRUMATCH CMF Solutions in Australia and Europe, excluding France. Such increase in collaborations by manufacturers to expand their portfolio is expected to drive the global craniomaxillofacial implants market growth.
Furthermore, in February 2019, ‘Renishaw’, a global engineering company, collaborated with two advanced technology companies, ‘Irish Manufacturing Research’ (IMR) and ‘nTopology’, to demonstrate the advantages of additive manufacturing (AM) in the production of spinal implants. Renishaw also uses its AM machines to produce healthcare products such as craniomaxillofacial implants and dental frameworks at its site in Miskin, South Wales.
Key Takeaways of the Market:
- The global craniomaxillofacial implants market is expected to exhibit a CAGR of 2% over the forecast period (2019–2027), owing to increasing product launches and product approvals.
- Among region, North America is expected to exhibit significant growth, owing to presence and variety of offerings by key players
- Asia Pacific region in the global craniomaxillofacial implants market is also expected to exhibit a high growth rate, owing to increasing awareness and need for such surgeries and high adoption rate of new technologies for treating maxillofacial injuries, over the forecast period.
- Some of the major players operating in the global craniomaxillofacial implants market include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic Inc., Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgical USA.
